Literature DB >> 20878632

Engineering nanocomposite materials for cancer therapy.

Caterina Minelli1, Stuart B Lowe, Molly M Stevens.   

Abstract

Cancer accounted for 13% of all deaths worldwide in 2005. Although early detection is critical for the successful treatment of many cancers, there are sensitivity limitations associated with current detection methodologies. Furthermore, many traditional anticancer drug treatments exhibit limited efficacy and cause high morbidity. The unique physical properties of nanoscale materials can be utilized to produce novel and effective sensors for cancer diagnosis, agents for tumor imaging, and therapeutics for cancer treatment. Functionalizing inorganic nanoparticles with biocompatible polymers and natural or rationally designed biomolecules offers a route towards engineering responsive and multifunctional composite systems. Although only a few such innovations have reached human clinical trial to date, nanocomposite materials based on functionalized metal and semiconductor nanoparticles promise to transform the way cancer is diagnosed and treated. This review summarizes the current state-of-the-art in the development of inorganic nanocomposites for cancer-related applications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20878632     DOI: 10.1002/smll.201000523

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  29 in total

Review 1.  Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms.

Authors:  Alicia Fernandez-Fernandez; Romila Manchanda; Anthony J McGoron
Journal:  Appl Biochem Biotechnol       Date:  2011-09-27       Impact factor: 2.926

2.  Cell-penetrating peptide enhanced intracellular Raman imaging and photodynamic therapy.

Authors:  Andrew M Fales; Hsiangkuo Yuan; Tuan Vo-Dinh
Journal:  Mol Pharm       Date:  2013-05-09       Impact factor: 4.939

Review 3.  Leukocytes as carriers for targeted cancer drug delivery.

Authors:  Michael J Mitchell; Michael R King
Journal:  Expert Opin Drug Deliv       Date:  2014-10-01       Impact factor: 6.648

Review 4.  Nanoparticles labeled with positron emitting nuclides: advantages, methods, and applications.

Authors:  Yongjian Liu; Michael J Welch
Journal:  Bioconjug Chem       Date:  2012-02-06       Impact factor: 4.774

5.  Surface patterning of nanoparticles with polymer patches.

Authors:  Rachelle M Choueiri; Elizabeth Galati; Héloïse Thérien-Aubin; Anna Klinkova; Egor M Larin; Ana Querejeta-Fernández; Lili Han; Huolin L Xin; Oleg Gang; Ekaterina B Zhulina; Michael Rubinstein; Eugenia Kumacheva
Journal:  Nature       Date:  2016-08-24       Impact factor: 49.962

Review 6.  Cancer cell invasion: treatment and monitoring opportunities in nanomedicine.

Authors:  Omid Veiseh; Forrest M Kievit; Richard G Ellenbogen; Miqin Zhang
Journal:  Adv Drug Deliv Rev       Date:  2011-02-02       Impact factor: 15.470

7.  In vitro activity of Paclitaxel-loaded polymeric expansile nanoparticles in breast cancer cells.

Authors:  Kimberly Ann V Zubris; Rong Liu; Aaron Colby; Morgan D Schulz; Yolonda L Colson; Mark W Grinstaff
Journal:  Biomacromolecules       Date:  2013-05-09       Impact factor: 6.988

8.  Advanced microscopy of star-shaped gold nanoparticles and their adsorption-uptake by macrophages.

Authors:  Germán Plascencia-Villa; Daniel Bahena; Annette R Rodríguez; Arturo Ponce; Miguel José-Yacamán
Journal:  Metallomics       Date:  2013-03       Impact factor: 4.526

9.  Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model.

Authors:  João Conde; Nuria Oliva; Yi Zhang; Natalie Artzi
Journal:  Nat Mater       Date:  2016-07-25       Impact factor: 43.841

Review 10.  Nanomedicine in chemoradiation.

Authors:  Seth M Miller; Andrew Z Wang
Journal:  Ther Deliv       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.